Diamyd_logo
Diamyd Shifts Away from Diabetes To Cut Costs
Diamyd Medical announced it has shifted its focus from the development of the diabetes therapy Diamyd® to the the development of drug candidates for the treatment of chronic pain....
Not Trying to Get my A1c Down
My HbA1c has been around 7% (6.8%-7.2%) for the last few years. Last year I tried terribly hard to get it down. I cut out almost all carbs, checked my…
No Longer Waiting
GS drove the thirty-minute drive to my doctor’s appointment so that I could sidestep stressing about the freeway traffic.  Yet as I sat in the passenger…
Summer Reading: Carolyn Ketchum Recommends…
I recently read Unbroken by Laura Hillenbrand, author of Seabiscuit. It's a non-fiction account of a man who was about to break the 4-minute mile back in the 1930's but then enlisted to fight in WWII and became a POW. It's truly a testament to the strength of the human spirit and the limits of human endurance.
Scallop Ceviche with Avocado and Mango
I recently had the pleasure of catering a dinner party in Dallas, Texas. Dallas has been in the midst of a heat wave for the past few weeks. It was miserably hot there so this light and refreshing ceviche dish was perfect for the party.
mannkind-logo
Mannkind Confirms Studies using Afrezza Insulin Threapy
MannKind Corporation announced that it has confirmed with the U.S. Food and Drug Administration the design of two clinical studies that evaluate the efficacy and safety of AFREZZA (insulin human [rDNA origin]), an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's next-generation inhaler...
The Insulin Truck (or so I thought)
I imagine all people with chronic illness have a complex relationship with the medications they need to survive. From the time of my diagnosis with…